FDA has received additional reports of fungal endophthalmitis (eye infections) in patients who were given Brilliant Blue G ( BBG ) during eye surgery since the FDA Warning to Physicians was posted on March 19, 2012.

The U.S. Food and Drug Administration (FDA) is warning of possible risks when using blood pressure medicines containing aliskiren with other drugs called angiotensin converting enzyme inhibitors ( ACEIs ) and angiotensin receptor blockers ( ARBs ) in patients with diabetes or kidney (renal) impairment.

FDA has received additional reports of fungal endophthalmitis (eye infections) in patients who were given Brilliant Blue G ( BBG ) during eye surgery since the FDA Warning to Physicians was posted on March 19, 2012.

FDA reminds patients, caregivers, and healthcare professionals of the importance of appropriate storage, use, application, and disposal of fentanyl patches (including Duragesic and generic products) to prevent potential life-threatening harm from accidental exposure to the active ingredient, fentanyl .

The U.S. Food and Drug Administration (FDA) has completed its review of recent observational ( epidemiologic ) studies regarding the risk of blood clots in women taking drospirenone-containing birth control pills.

The U.S. Food and Drug Administration approved Amyvid ( Florbetapir F 18 Injection) a drug for Positron Emission Tomography (PET) imaging of the brain in adults who are being evaluated for Alzheimer's Disease (AD) and other causes of cognitive decline.

The U.S. Food and Drug Administration (FDA) is clarifying dosing and warning recommendations for the antidepressant Celexa ( citalopram hydrobromide ; also available in generic form).

FDA lab tests have confirmed that a counterfeit version of Roche’s Altuzan 400mg / 16ml ( bevacizumab ),an injectable cancer medication, found in the U.S. contains no active ingredient.

Two new pancreatic enzyme products used to help aid food digestion, Ultresa ( pancrelipase ) and Viokace ( pancrelipase ), were approved by the U.S. Food and Drug Administration.

Avioq HTLV-I /II Microelisa System, a test designed to detect antibodies to viruses in donors of human blood and blood components that are associated with several diseases, including some forms of leukemia and neurologic diseases, was approved by the Food and Drug Administration.